Literature DB >> 16858391

Therapeutic interventions after spinal cord injury.

Sandrine Thuret1, Lawrence D F Moon, Fred H Gage.   

Abstract

Spinal cord injury (SCI) can lead to paraplegia or quadriplegia. Although there are no fully restorative treatments for SCI, various rehabilitative, cellular and molecular therapies have been tested in animal models. Many of these have reached, or are approaching, clinical trials. Here, we review these potential therapies, with an emphasis on the need for reproducible evidence of safety and efficacy. Individual therapies are unlikely to provide a panacea. Rather, we predict that combinations of strategies will lead to improvements in outcome after SCI. Basic scientific research should provide a rational basis for tailoring specific combinations of clinical therapies to different types of SCI.

Entities:  

Mesh:

Year:  2006        PMID: 16858391     DOI: 10.1038/nrn1955

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  312 in total

1.  Active scaffolds for on-demand drug and cell delivery.

Authors:  Xuanhe Zhao; Jaeyun Kim; Christine A Cezar; Nathaniel Huebsch; Kangwon Lee; Kamal Bouhadir; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

2.  Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Authors:  Xingxing Wang; Omar Hasan; Alexander Arzeno; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Exp Neurol       Date:  2012-06-21       Impact factor: 5.330

3.  Reprogramming axonal behavior by axon-specific viral transduction.

Authors:  B A Walker; U Hengst; H J Kim; N L Jeon; E F Schmidt; N Heintz; T A Milner; S R Jaffrey
Journal:  Gene Ther       Date:  2012-01-26       Impact factor: 5.250

4.  Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma.

Authors:  Akram M Zaaqoq; Rami Namas; Khalid Almahmoud; Nabil Azhar; Qi Mi; Ruben Zamora; David M Brienza; Timothy R Billiar; Yoram Vodovotz
Journal:  Crit Care Med       Date:  2014-06       Impact factor: 7.598

5.  Valproic acid preserves motoneurons following contusion in organotypic spinal cord slice culture.

Authors:  Sareh Pandamooz; Mohammad Saied Salehi; Mohammad Nabiuni; Leila Dargahi
Journal:  J Spinal Cord Med       Date:  2016-08-31       Impact factor: 1.985

Review 6.  Mesenchymal stem cells in the treatment of spinal cord injuries: A review.

Authors:  Venkata Ramesh Dasari; Krishna Kumar Veeravalli; Dzung H Dinh
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

7.  A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury.

Authors:  Nishanth Lakshman; Wenjun Xu; Cindi M Morshead
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

8.  Bridging defects in chronic spinal cord injury using peripheral nerve grafts combined with a chitosan-laminin scaffold and enhancing regeneration through them by co-transplantation with bone-marrow-derived mesenchymal stem cells: case series of 14 patients.

Authors:  Sherif M Amr; Ashraf Gouda; Wael T Koptan; Ahmad A Galal; Dina Sabry Abdel-Fattah; Laila A Rashed; Hazem M Atta; Mohammad T Abdel-Aziz
Journal:  J Spinal Cord Med       Date:  2013-11-26       Impact factor: 1.985

9.  FK506 Attenuates the Inflammation in Rat Spinal Cord Injury by Inhibiting the Activation of NF-κB in Microglia Cells.

Authors:  Gang Liu; Gentao Fan; Guodong Guo; Wenbo Kang; Dongsheng Wang; Bin Xu; Jianning Zhao
Journal:  Cell Mol Neurobiol       Date:  2016-08-29       Impact factor: 5.046

10.  Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress.

Authors:  Liu Jinbo; Liu Zhiyuan; Zhang Zhijian; Ding WenGe
Journal:  Cell Mol Neurobiol       Date:  2013-04-14       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.